The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported ...
UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback